These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 949890

  • 1. Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers.
    Koch UJ, Lorenz F, Danehl K, Ericsson R, Hasan SH, Keyserlingk DV, Lübke K, Mehring M, Römmler A, Schwartz U, Hammerstein J.
    Contraception; 1976 Aug; 14(2):117-35. PubMed ID: 949890
    [Abstract] [Full Text] [Related]

  • 2. Use of low-dosage oral cyproterone acetate as a male contraceptive.
    Wang C, Yeung KK.
    Contraception; 1980 Mar; 21(3):245-72. PubMed ID: 6771091
    [Abstract] [Full Text] [Related]

  • 3. Effects of cyproterone acetate on reproductive functions in normal human males.
    Roy S, Chatterjee S, Prasad MR, Poddar AK, Pandey DC.
    Contraception; 1976 Oct; 14(4):403-20. PubMed ID: 975826
    [Abstract] [Full Text] [Related]

  • 4. Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.
    Moltz L, Römmler A, Post K, Schwartz U, Hammerstein J.
    Contraception; 1980 Apr; 21(4):393-413. PubMed ID: 6771095
    [Abstract] [Full Text] [Related]

  • 5. Studies with cyproterone acetate for male contraception.
    Roy S, Chatterjee S.
    J Steroid Biochem; 1979 Jul; 11(1B):675-80. PubMed ID: 491632
    [Abstract] [Full Text] [Related]

  • 6. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC, Jouannet P, Marson J, Soumah A.
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [Abstract] [Full Text] [Related]

  • 7. The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men.
    Føgh M, Corker CS, Hunter WM, McLean H, Philip J, Schou G, Skakkebaek NE.
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):545-52. PubMed ID: 474042
    [Abstract] [Full Text] [Related]

  • 8. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI, Das RP, Madoiya KK, Jain AK, Roy S.
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [Abstract] [Full Text] [Related]

  • 9. The influence of pharmaceutical compounds on male fertility.
    Neumann F, Diallo FA, Hasan SH, Schenck B, Traore I.
    Andrologia; 1976 Nov; 8(3):203-35. PubMed ID: 793446
    [Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men.
    Foegh M, Nicol K, Petersen IB, Schou G.
    Contraception; 1980 Jun; 21(6):631-40. PubMed ID: 6775869
    [Abstract] [Full Text] [Related]

  • 11. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA, Yeung CH, Nieschlag E.
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [Abstract] [Full Text] [Related]

  • 12. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [Abstract] [Full Text] [Related]

  • 13. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC, Bremner WJ, Costantino A, Di Cintio G, Flamigni C.
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [Abstract] [Full Text] [Related]

  • 14. Cyproterone acetate: II. failure to reduce sperm fertility in the surgically separated epididymis of rat.
    Chatterjee A, Pal AK, Ray P, Basu R.
    Contraception; 1977 Apr; 15(4):429-34. PubMed ID: 880818
    [Abstract] [Full Text] [Related]

  • 15. Effect of cyproterone acetate (CPA) on gonadal and adrenal function in men.
    de la Torre B, Norén S, Hedman M, Diczfalusy E.
    Contraception; 1979 Oct; 20(4):377-96. PubMed ID: 228907
    [Abstract] [Full Text] [Related]

  • 16. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles.
    Cooper AJ, Sandhu S, Losztyn S, Cernovsky Z.
    Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073
    [Abstract] [Full Text] [Related]

  • 17. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy.
    Reinberg A, Smolensky MH, Hallek M, Smith KD, Steinberger E.
    Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279
    [Abstract] [Full Text] [Related]

  • 18. Effect of administration of a single dose of testosterone oenanthate on constituents of human seminal plasma and serum gonadotropins.
    Sheth AR, Jayatilak PG, Thakur AN, Mugatwala P, Pardanani DS.
    Andrologia; 1976 Feb; 8(3):259-64. PubMed ID: 999044
    [Abstract] [Full Text] [Related]

  • 19. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
    Meriggiola MC, Bremner WJ, Paulsen CA, Valdiserri A, Incorvaia L, Motta R, Pavani A, Capelli M, Flamigni C.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3018-23. PubMed ID: 8768868
    [Abstract] [Full Text] [Related]

  • 20. Effects of low doses of cyproterone acetate on sperm morphology and some other parameters of reproduction in normal men.
    Fredricsson B, Carlström K.
    Andrologia; 1981 Aug; 13(4):369-75. PubMed ID: 6456681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.